Keap1 expression was inversely correlated with the clinical stage and lymph node metastasis and early-stage tumors (I) without lymph node metastasis had higher levels of Keap1 expression compared with late-stage tumors (II and III). The gene discussed is KEAP1; the disease is metastatic malignant neoplasm in the lymph nodes.